Arcturus Therapeutics
ARCT
32 hedge funds and large institutions have $83.2M invested in Arcturus Therapeutics in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
62% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $694K
48% more capital invested
Capital invested by funds: $56.1M → $83.2M (+$27.1M)
14% more funds holding
Funds holding: 28 → 32 (+4)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.99M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$9.54M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.34M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.24M |
| 5 |
FAM
Fred Alger Management
New York
|
+$761K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$2.13M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$1.31M |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$1.28M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$440K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$311K |
ARCT Hedge Fund Activity: Q2 2015 in Review
32 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q2 2015, worth a combined $83.2M — up 48% from $56.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ARCT positions and 6 closed out — a net gain of 4 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $9.99M. The largest seller was Deerfield Management, cutting an estimated $2.13M.
- 32 institutional investors held Arcturus Therapeutics (ARCT) as of Q2 2015, up from 28 in Q1 2015.
- Funds reported $83.2M of Arcturus Therapeutics stock for Q2 2015, up 48% quarter-over-quarter.
- 10 funds opened new Arcturus Therapeutics positions in Q2 2015 and 6 closed out, a net change of +4 holders.
- The largest Arcturus Therapeutics buyer in Q2 2015 was RA Capital Management, an estimated $9.99M added.
- The largest Arcturus Therapeutics seller in Q2 2015 was Deerfield Management, an estimated $2.13M sold.
Based on aggregated 13F filings for Q2 2015.